Active Clinical Trials

Carotid Artery Disease

CREST-2; McLaren; Intense Medical Management (IMM) alone vs. Carotid Stent + IMM vs. Carotid Endarterectomy + IMM (open to enrollment)

ROADSTER 2; McLaren; Transcarotid Stenting with Transcarotid Neuroprotection (open to enrollment)


Aortic Aneurysmal Disease

ANCHOR; McLaren, Hurley, Genesys: Aptus AAA aortic securement system (open to enrollment)

Anaconda; McLaren; Infrarenal (<60) degree angled neck abdominal aortic stent graft (in-follow-up)

The GREAT Registry; McLaren; Endovascular Treatment of Abdominal Aortic Aneurysms, Outcomes Registry (open to enrollment)

Peripheral Arterial Disease

MIMICS-2;  Michigan Vascular Access Center; Superficial Femoral Artery Stent (open to enrollment)

BEST-CLI: McLaren, Endovascular vs Surgical Repair of PAD in patients with Critical Limb Ischemia (open to enrollment)

Humacyte (for PAD); McLaren, Human Acellular Vessel (HAV) for treatment of PAD (coming soon)

Past Research Trials

Carotid Stenting - 21

Carotid Plaque Evaluation - 1

Carotid Stent Surveillance - 2

Abdominal Aortic Aneurysm Endograft - 6

Aortic Graft Securement - 1

Abdominal Aortic Aneurysm Sensor - 1

Peripheral Stenting - 3

Peripheral Stent/Drug Eluting - 2

Renal Stenting - 1

Renal Lesions Outcome - 1

Peripheral Arterial Disease (PAD) Drug Trials - 7

Deep Venous Thrombosis (DVT) Trials - 2

Inferior Vena Cava (IVC) Filter - 1

Surgical Hemostasis - 3

Wound Covering - 1

Hemodialysis Access Stent - 1

Hemodialysis Access Wrap - 3

Arterio-Venous Fistula (AVF) Drug Study - 1

Retrospective Data Studies - 5

Renal/Hemodialysis Studies

Lutonix AV Study; Michigan Vascular Access Center; Drug coated Balloon PTA vs. Standard Balloon PTA for Dysfunctional AV Fistulae (in follow-up)

Humacyte (for Dialysis); Michigan Vascular Access Center; Human Acellular Vessel (HAV) vs. ePTFE Grafts for Dialysis Conduits (open to enrollment) 

Venous Disease

VIRTUS; Michigan Vascular Access Center; Venous Stenting of Iliofemoral Venous Segment (open to enrollment)